LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Michael Snabes, its medical director, will be presenting a LibiGel® (transdermal testosterone gel) poster at a meeting of the Sexual Medicine Society of North America (SMSNA) at the Westin Chicago River North on Sunday December 9, 2007. The SMSNA fall meeting is attended by practitioners and scientists and is a dynamic scientific meeting with presentations on basic science and clinical developments in the area of sexual medicine.
